Annual D&A
$27.61M$20.88M-43.06%
Summary
- Current Value
- As of today, NVAX annual D&A is $27.61M, down -43.06% on
- Historical Performance
- NVAX annual D&A is down -4.96% over the past 3 years, up +465.26% over the past 5 years
- All-Time High Comparison
- NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on
- 3-Year Low Comparison
- NVAX annual D&A is at its 3-year low
- Sector Comparison
- NVAX annual D&A is higher than 80.41% of companies in Healthcare sector
Depreciation & Amortization Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $27.61M | -43.1% | -5.0% | +465.3% | +1912.6% | ||
| $3.06M | -59.6% | -69.6% | +26.8% | +665.9% | ||
| $17.83M | -56.6% | -48.6% | +131.3% | +1455.7% | ||
| Price | $12.66 | +52.0% | +69.9% | -92.2% | -62.3% | |
| $157.48M | -53.3% | -67.8% | +8.4% | +1357.5% | ||
| $683.18M | -21.4% | -74.1% | -23.6% | +1795.0% | ||
| $489.07M | -31.7% | -71.6% | +18.1% | +1170.5% | ||
| $1.12B | +64.7% | -43.3% | +136.2% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $48.50M | -43.1% | |
| 5Y | $48.50M | -43.1% | |
| All | $48.50M | -43.1% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $27.61M | at low | |
| 5Y | $4.89M | N/A | +465.3% |
| All | $253.60K | >+9999.0% |
Depreciation & Amortization History
FAQ
- What is the current annual D&A of NVAX?
- As of today, NVAX annual D&A is $27.61M
- What is 1-year change in NVAX annual D&A?
- NVAX annual D&A is down -43.06% year-over-year
- What is 3-year change in NVAX annual D&A?
- NVAX annual D&A is down -4.96% over the past 3 years
- How far is NVAX annual D&A from its all-time high?
- NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024
- How does NVAX annual D&A rank versus sector peers?
- NVAX annual D&A is higher than 80.41% of companies in Healthcare sector
- When is NVAX next annual earnings release?
- As of today, the next annual earnings release for NVAX has not been scheduled
Quarterly D&A
$3.06M$6,000.00-0.20%
Summary
- Current Value
- As of today, NVAX quarterly D&A is $3.06M, down -0.20% on
- Historical Performance
- NVAX quarterly D&A is down -59.59% year-over-year, down -69.64% over the past 3 years
- All-Time High Comparison
- NVAX quarterly D&A is currently -75.94% below its historical high of $12.70M set on
- 3-Year Low Comparison
- NVAX quarterly D&A is at its 3-year low
- Sector Comparison
- NVAX quarterly D&A is higher than 70.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $3.06M | -0.2% | -59.6% | -69.6% | +26.8% | ||
| $27.61M | – | -43.1% | -5.0% | +465.3% | ||
| $17.83M | -20.2% | -56.6% | -48.6% | +131.3% | ||
| Price | $12.66 | +35.7% | +52.0% | +69.9% | -92.2% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $110.09M | -26.1% | -17.1% | -70.0% | -83.1% | ||
| $97.36M | -18.1% | -18.4% | -67.4% | -71.8% | ||
| $56.70M | -59.4% | -76.3% | -86.6% | -81.0% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $6.59M | N/A | -53.6% |
| 3Y | $12.70M | -75.9% | |
| 5Y | $12.70M | -75.9% | |
| All | $12.70M | -75.9% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.06M | at low | |
| 3Y | $3.06M | at low | |
| 5Y | $3.06M | at low | |
| All | -$1.36M | +324.5% |
Quarterly D&A History
FAQ
- What is the current quarterly D&A of NVAX?
- As of today, NVAX quarterly D&A is $3.06M
- What is NVAX quarterly D&A most recent change?
- NVAX quarterly D&A was down -0.20% on June 30, 2026
- What is 1-year change in NVAX quarterly D&A?
- NVAX quarterly D&A is down -59.59% year-over-year
- How far is NVAX quarterly D&A from its all-time high?
- NVAX quarterly D&A is currently -75.94% below its historical high of $12.70M set on September 30, 2024
- How does NVAX quarterly D&A rank versus sector peers?
- NVAX quarterly D&A is higher than 70.91% of companies in Healthcare sector
- When is NVAX next earnings release?
- The next earnings release for NVAX is on
TTM D&A
$17.83M$4.51M-20.18%
Summary
- Current Value
- As of today, NVAX TTM D&A is $17.83M, down -20.18% on
- Historical Performance
- NVAX TTM D&A is down -56.64% year-over-year, down -48.59% over the past 3 years
- All-Time High Comparison
- NVAX TTM D&A is currently -63.24% below its historical high of $48.50M set on
- 3-Year Low Comparison
- NVAX TTM D&A is at its 3-year low
- Sector Comparison
- NVAX TTM D&A is higher than 74.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $17.83M | -20.2% | -56.6% | -48.6% | +131.3% | ||
| $27.61M | – | -43.1% | -5.0% | +465.3% | ||
| $3.06M | -0.2% | -59.6% | -69.6% | +26.8% | ||
| Price | $12.66 | +35.7% | +52.0% | +69.9% | -92.2% | |
| -$18.36B | -10000.0% | -7725.9% | -3841.4% | -7313.9% | ||
| $413.80M | -30.6% | -61.6% | -74.1% | -65.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $35.01M | N/A | -49.1% |
| 3Y | $48.50M | -63.2% | |
| 5Y | $48.50M | -63.2% | |
| All | $48.50M | -63.2% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $17.83M | at low | |
| 3Y | $17.83M | at low | |
| 5Y | $10.78M | N/A | +65.3% |
| All | -$780.00K | +2385.6% |
TTM D&A History
FAQ
- What is the current TTM D&A of NVAX?
- As of today, NVAX TTM D&A is $17.83M
- What is NVAX TTM D&A most recent change?
- NVAX TTM D&A was down -20.18% on June 30, 2026
- What is 1-year change in NVAX TTM D&A?
- NVAX TTM D&A is down -56.64% year-over-year
- How far is NVAX TTM D&A from its all-time high?
- NVAX TTM D&A is currently -63.24% below its historical high of $48.50M set on December 31, 2024
- How does NVAX TTM D&A rank versus sector peers?
- NVAX TTM D&A is higher than 74.00% of companies in Healthcare sector
- When is NVAX next earnings release?
- The next earnings release for NVAX is on
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069426000007/0001000694-26-000007-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax
